2017 Conference on Retroviruses and Opportunistic Infections*

February 13-16, 2017; Seattle, Washington
Get up to date on the latest HIV data with rapid Capsule Summaries, downloadable slidesets, and live, expert-led Webinars covering key studies from Seattle.
Joel E. Gallant, MD, MPH
Charles B. Hicks, MD

ClinicalThought

Recent data highlighting the potential for CNS effects with newer INSTIs has given me a sense of déjà vu about how we once approached the same issue with efavirenz. Here’s my take on what we know and how to proceed.

Joel E. Gallant, MD, MPH Released: April 5, 2017

PrEP offers an important option for curtailing HIV transmission. This review of new data from CROI emphasizes what management considerations must accompany its use.

Charles B. Hicks, MD Released: April 27, 2017
Jointly provided by Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC.
ACHS Logo

Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Dr
Dinah Shore Bldg.
Rancho Mirage, CA 92270

Melissa Velasquez, Accreditation Specialist
(760) 773-4506
(760) 773-4550 (Fax)
ce@annenberg.net
http://www.annenberg.net/

Supported by independent educational grants from
Gilead Sciences
Merck & Co., Inc.
Theratechnologies Inc.
ViiV Healthcare

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue